PCI Biotech Holding ASA

OB:PCIB Stock Report

Market Cap: NOK 65.3m

PCI Biotech Holding Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ronny Skuggedal

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11yrs
CEO ownership0.1%
Management average tenureno data
Board average tenure8.4yrs

Recent management updates

Recent updates

We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

Aug 05
We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully

Apr 21
We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully

We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely

Dec 16
We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely

We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

Apr 09
We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate

What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?

Feb 15
What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?

PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans

Dec 22
PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has Ronny Skuggedal's remuneration changed compared to PCI Biotech Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-NOK 16m

Mar 31 2024n/an/a

-NOK 18m

Dec 31 2023n/an/a

-NOK 20m

Sep 30 2023n/an/a

-NOK 23m

Jun 30 2023n/an/a

-NOK 29m

Mar 31 2023n/an/a

-NOK 38m

Dec 31 2022n/an/a

-NOK 55m

Sep 30 2022n/an/a

-NOK 73m

Jun 30 2022n/an/a

-NOK 84m

Mar 31 2022n/an/a

-NOK 88m

Dec 31 2021NOK 2mNOK 2m

-NOK 88m

Sep 30 2021n/an/a

-NOK 90m

Jun 30 2021n/an/a

-NOK 90m

Mar 31 2021n/an/a

-NOK 100m

Dec 31 2020NOK 3mNOK 1m

-NOK 72m

Sep 30 2020n/an/a

-NOK 71m

Jun 30 2020n/an/a

-NOK 64m

Mar 31 2020n/an/a

-NOK 61m

Dec 31 2019NOK 2mNOK 1m

-NOK 89m

Sep 30 2019n/an/a

-NOK 68m

Jun 30 2019n/an/a

-NOK 62m

Mar 31 2019n/an/a

-NOK 43m

Dec 31 2018NOK 2mNOK 1m

-NOK 35m

Sep 30 2018n/an/a

-NOK 46m

Jun 30 2018n/an/a

-NOK 48m

Mar 31 2018n/an/a

-NOK 48m

Dec 31 2017NOK 1mNOK 1m

-NOK 43m

Compensation vs Market: Insufficient data to establish whether Ronny's total compensation is reasonable compared to companies of similar size in the Norwegian market.

Compensation vs Earnings: Ronny's compensation has been consistent with company performance over the past year.

CEO

Ronny Skuggedal (48 yo)

11yrs

Tenure

Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...

Board Members

NamePositionTenureCompensationOwnership
Hans Bohn
Independent Chairman9.4yrsNOK 355.00k0.33%
NOK 216.4k
Lars Viksmoen
Independent Director8.4yrsNOK 220.00k0.035%
NOK 22.7k
Hilde Furberg
Independent Director5.4yrsNOK 220.00kno data

8.4yrs

Average Tenure

69yo

Average Age

Experienced Board: PCIB's board of directors are considered experienced (8.4 years average tenure).